Elidah
CT - NewtownBiotechnology
Focus: Elidah is a newly founded (2024) biotechnology company headquartered in Newtown, CT, specializing in pelvic floor stimulation devices for urinary incontinence and related disorders. The company is publicly listed and focuses on transcutaneous and surface electrical stimulation modalities.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Elidah
AI assessmentNot HiringNo open roles listed right now. Follow Elidah to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Elidah's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ELITONE UUI
Urge IncontinenceClinical Trials (1)
NCT04752709Efficacy of Surface Electrical Stimulation for Urge Urinary Incontinence in Women
N/AHelp build intelligence for Elidah
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.